Senti Biosciences Holdings (SNTI) Assets (2021 - 2025)
Senti Biosciences Holdings (SNTI) posted quarterly Assets of $51.2 million for Q4 2025, down 47.65% year-over-year from $97.8 million in Q4 2024, and down 2.77% quarter-over-quarter from $52.7 million in Q3 2025.
Senti Biosciences Holdings (SNTI) Assets (2021 - 2025) Analysis & Trends
Senti Biosciences Holdings' Assets history runs 5 years deep, the most recent figure standing at $51.2 million for Q4 2025.
- In Q4 2025, Assets fell 47.65% year-over-year to $51.2 million; the TTM figure through Dec 2025 stood at $51.2 million (down 47.65% YoY), while the FY2025 annual figure was $51.2 million, down 47.65% from the prior year.
- Assets for Q4 2025 stood at $51.2 million, down from $52.7 million in the prior quarter.
- The five-year high for Assets was $231.9 million in Q2 2021, with the low at $373657.0 in Q1 2021.
- The 5-year median for Assets is $110.8 million (2023), against an average of $126.0 million.
- The sharpest annual moves came in 2022 and 2024: Assets soared 61698.89% in 2022, then slumped 56.19% in 2024.
- Senti Biosciences Holdings' Assets stood at $96.7 million in 2021, then jumped by 86.96% to $180.8 million in 2022, then tumbled by 33.91% to $119.5 million in 2023, then fell by 18.11% to $97.8 million in 2024, then sank by 47.65% to $51.2 million in 2025.
- Business Quant data shows SNTI's Assets at $51.2 million in Q4 2025, $52.7 million in Q3 2025, and $68.5 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 10.03 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 10.96 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 9.18 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 5.56 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 2.10 Bn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 19.82 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 25.60 Bn |
| 10 | Senti Biosciences Holdings | 13.66 Mn | 13.66 Mn | - | 33.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 51.22 Mn |
| Sep 30, 2025 | 52.69 Mn |
| Jun 30, 2025 | 68.54 Mn |
| Mar 31, 2025 | 82.78 Mn |
| Dec 31, 2024 | 97.84 Mn |
| Sep 30, 2024 | 57.72 Mn |
| Jun 30, 2024 | 86.91 Mn |
| Mar 31, 2024 | 102.19 Mn |
| Dec 31, 2023 | 119.48 Mn |
| Sep 30, 2023 | 131.77 Mn |
| Jun 30, 2023 | 143.63 Mn |
| Mar 31, 2023 | 161.43 Mn |
| Dec 31, 2022 | 180.79 Mn |
| Sep 30, 2022 | 189.44 Mn |
| Jun 30, 2022 | 202.36 Mn |
| Mar 31, 2022 | 230.92 Mn |
| Dec 31, 2021 | 96.70 Mn |
| Sep 30, 2021 | 231.66 Mn |
| Jun 30, 2021 | 231.89 Mn |
| Mar 31, 2021 | 373,657.00 |